✦ LIBER ✦

Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment–Thrombolysis In Myocardial Infarction study 25 (ExTRACT–TIMI 25) trial

✍ Scribed by David A. Morrow; Elliott M. Antman; Sabina A. Murphy; Jie Qin; Mikhail Ruda; Sema Guneri; Ashok Joseph Jacob; Andrzej Budaj; Eugene Braunwald

Book ID: 116191119
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 379 KB
Volume: 154
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2007.07.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enoxaparin versus unfractionated heparin

Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction: Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25)

✍ Elliott M. Antman; David A. Morrow; Carolyn H. McCabe; Frank Jiang; Harvey D. Wh 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 631 KB

Global outcomes of ST-elevation myocardi

Global outcomes of ST-elevation myocardial infarction: Comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial

✍ Benjamin A. Steinberg; Nazanin Moghbeli; Jacqueline Buros; Mikhail Ruda; Alexand 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Comparison of Effectiveness of Enoxapari

Comparison of Effectiveness of Enoxaparin Versus Unfractionated Heparin to Reduce Silent and Clinically Apparent Acute Myocardial Infarction in Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndrome

✍ Sanjit Jolly; Mary Tan; Aurora Mendelsohn; David Fitchett; Paul W. Armstrong; An 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Efficacy and safety of enoxaparin compar

Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trial

✍ Shahar Lavi; Warren J. Cantor; Amparo Casanova; Mary K. Tan; Andrew T. Yan; Vlad 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 229 KB

The safety and efficacy of subcutaneous

The safety and efficacy of subcutaneous enoxaparin vs. intravenous unfractionated heparin and tirofiban vs. placebo in the treatment of acute st-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial

✍ M Cohen; G.F Gensini; F Maritzet al 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 45 KB

The TETAMI Trial: The Safety and Efficac

The TETAMI Trial: The Safety and Efficacy of Subcutaneous Enoxaparin versus Intravenous Unfractionated Heparin and of Tirofiban versus Placebo in the Treatment of Acute Myocardial Infarction for Patients Not Thrombolyzed: Methods and Design

✍ Marc Cohen; Frans Maritz; Gian Franco Gensini; Nicolas Danchin; Ari Timerman; Ku 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 93 KB